Bassam Francis Matti Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

12/2014	Assessment of interleukin 1β serum level in different responder groups and stages of chronic myeloid leukemia patients on imatinb mesylate therapy.
12/2013	Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bassam Francis Matti Research Topics

Disease

2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2014 - 12/2013
1	Leukemia 12/2014
1	Neoplasms (Cancer) 12/2014

Drug/Important Bio-Agent (IBA)

1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2014
1	CytokinesIBA 12/2014
1	fludarabineIBA 12/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2014
1	InterleukinsIBA 12/2014
1	Mesylates (Mesylate)IBA 12/2014
1	Tyrosine Kinase InhibitorsIBA 12/2013
1	Imatinib Mesylate (Gleevec)FDA Link 12/2013
1	Pharmaceutical PreparationsIBA 12/2013

Therapy/Procedure

1	FLAG protocol 12/2014
1	Salvage Therapy 12/2014
1	Therapeutics 12/2014